CMS, GE HealthCare, Sectra and Provect AI Reshape Imaging Capacity – July 17, 2026
Marketstrat analyzes how CMS, GE HealthCare, Sectra and Provect AI are shifting imaging value toward capacity, workflow control and governance. 🎧 Listen to this week’s Marketstrat Pulse Insight: CMS, GE HealthCare, Sectra and Provect AI Signal a New Imaging Capacity-Control Market Medical imaging has traditionally evaluated value at the level of the asset or algorithm. […]
The Shift to Capacity Control
Market Signal – July 10, 2026 Imaging AI must increasingly prove that it can be paid, distributed or converted into operating capacity.
CMS, Heartflow, Cleerly, Viz.ai and Philips Reframe Imaging AI Economics – July 10, 2026
Marketstrat analyzes how CMS, Heartflow, Cleerly, Viz.ai and Philips are shifting imaging AI toward payment, workflow control and capacity. 🎧 Listen to this week’s Marketstrat Pulse Insight: Medical imaging AI is entering a more demanding stage of commercialization. Regulatory clearance still matters, but the week ending July 10, 2026 showed that payment architecture, workflow control […]
Aidoc, DeepHealth/RadNet, GuideAI and HOPPR Move Imaging AI Beyond Clearance – June 26, 2026
The week ending June 26 showed that imaging AI adoption now depends on workflow governance, platform layering, reimbursement, enterprise distribution and supply resilience. Imaging AI activity resumed across CT, MRI and mammography, but the week’s bigger signal was not clearance volume. Aidoc and HOPPR moved report drafting toward the next workflow frontier. DeepHealth/RadNet expanded mammography […]
Midjourney Medical, Butterfly Network and AIRS Medical Shift Imaging AI Toward Distribution, Capacity and Regulated Updates – June 19, 2026
Consumer-led imaging, embedded ultrasound components, MRI capacity software and FDA’s controlled-update framework are expanding the definition of an imaging AI platform. Estimated read time: 6 minutes The most consequential imaging AI signals this week were not additional point algorithms. Midjourney Medical tested a consumer-led distribution model, Butterfly Network expanded ultrasound into embedded component licensing, AIRS […]
Reporting AI: The New Control Layer for Medical Imaging
Market Signal – June 12, 2026 The center of gravity in imaging AI is fundamentally shifting. In our analysis, the market has moved definitively past standalone detection algorithms and is now ruthlessly prioritizing operating infrastructure embedded directly into the radiologist’s daily workflow. This infographic captures the most aggressive commercial pivot we are tracking this week: […]
Imaging AI Market Signal – The Shift to Platform Control
Market Signal – June 5, 2026 The medical imaging market has exited the era of standalone AI features and is aggressively repricing around platform control. Healthcare systems are no longer simply buying diagnostic algorithms; they are buying operating infrastructure designed to directly attack their severe labor and capacity constraints. What the visual is telling us: […]
RadNet/DeepHealth, GE HealthCare and Rad AI Turn Reporting AI Into Imaging’s Control Layer – June 12, 2026
The week ending June 12 showed imaging AI moving beyond point algorithms and into reporting workflow, enterprise imaging workspaces, validation infrastructure, and operational capacity. This week’s Marketstrat Pulse points to a structural shift in imaging AI. The highest-signal activity was not another standalone detection model. It was the concentration of reporting-native AI, cloud enterprise imaging, […]
Imaging AI Moves From Point Solutions to Platform Control – June 5, 2026
The week ending June 5, 2026 showed imaging AI becoming infrastructure for workflow, capacity, oncology planning, nuclear medicine, and outpatient distribution. 🎧 Listen to this week’s Marketstrat Pulse Insight: Estimated read time: 5 minutes This week’s Marketstrat Pulse shows a clear shift in imaging AI strategy. The strongest signals were not isolated algorithms. They came […]
Imaging Infrastructure Gets Repriced – May 29, 2026
I-MED’s A$3.4B sale, SubtleHD(PET)’s FDA clearance, CBCT perfusion, cloud-native teleradiology, and payer friction relief point to a market valuing infrastructure over standalone AI. 🎧 Listen to this week’s Marketstrat Pulse Insight: The latest Marketstrat Pulse highlights a shift in medical imaging: the strongest commercial signals are clustering around assets that control bottlenecks. Jardine Matheson’s A$3.4B […]
